Li Ren, Ph.D., is a seasoned biotech professional and executive leader currently serving as the Chief Technology Officer at 克睿基因 Cure Genetics. With over 20 years of experience in cell therapy development, Li previously held key roles as Director of Global Manufacturing Science & Technology at Bristol-Myers Squibb and VP, Head of Technical Operations at Chimeric Therapeutics. Li has played a pivotal role in advancing innovative cell therapies, managing regulatory filings, and establishing successful collaborations across various projects. Li earned a Ph.D. in Biochemistry and Molecular Biology from Peking University and is pursuing a Mini-MBA in BioPharma Innovation at Rutgers University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices